AHPA Rewrites NDI Guidance, Argues FDA Proposes Premarket Approval For Supplements
This article was originally published in The Tan Sheet
Executive Summary
The NDI draft guidance “seeks to erect extra-legal barriers to market entry” and change supplement regulation “from the notification process described under law to an FDA approval process,” AHPA argues, joining other trade groups urging FDA to withdraw the guidance
You may also be interested in...
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.
TheraBiogen Supports Theramax Expansion With Education Push
Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.